top of page

Spring 2026 Women’s Health Update: WID-easy & National Maternity Evaluations


As we move through Spring 2026, women’s healthcare services across the UK continue to evolve in response to changing clinical demands, workforce pressures, and national healthcare priorities.


AGHealth remain committed to supporting NHS teams with innovative diagnostics, induction solutions, and clinical implementation support designed to improve patient experience and operational efficiency.


In this edition, we explore:




National Prostin Shortage Continues to Impact Induction Pathways


Ongoing national supply challenges with Prostin are continuing to affect induction of labour pathways across NHS maternity services.

In response, many trusts are reviewing and adapting local protocols to ensure continuity of care while maintaining safe and effective induction practices.


Mechanical cervical ripening methods such as DILAPAN-S are increasingly being adopted because they:

  • Provide a reliable and predictable alternative

  • Are not dependent on pharmaceutical supply chains

  • Support both inpatient and outpatient pathways

  • Are associated with a favourable safety profile


AGHealth is actively supporting NHS teams through:

  • Clinical training

  • Protocol development

  • Service implementation guidance


These measures are helping trusts rapidly integrate DILAPAN-S into existing induction pathways during this period of supply instability.

If your service is currently reviewing induction practices or experiencing supply challenges, our clinical team is available to help.





WID-easy Service Evaluations Expand Across NHS Sites


WID-easy service evaluations continue to expand across NHS organisations, helping clinicians improve the triage of women referred through suspected cancer pathways with abnormal uterine bleeding (AUB).


These evaluations, supported and funded by regional Cancer Alliances, aim to better understand:

  • Real-world operational use of the WID-easy test

  • Impact on Faster Diagnosis Standard (FDS) compliance

  • Potential reductions in procedural burden

  • Cost-saving opportunities within local pathways


Alongside these NHS evaluations, an important new peer-reviewed cost-minimisation analysis has recently been published in Value in Health.


The analysis demonstrated that WID-easy may provide both a clinically effective and economically advantageous alternative to transvaginal ultrasound (TVUS) as a first-line triage test for patients presenting with AUB on the Urgent Suspected Cancer pathway.


Key findings included:

  • A greater than 99% probability of cost savings when using WID-easy within the Urgent Suspected Cancer pathway

  • Potential reductions in unnecessary investigations and resource utilisation

  • Opportunities to streamline patient pathways and improve efficiency





Renewed Women’s Health Strategy Signals Important Progress


The renewed Women’s Health Strategy for England marks an important milestone for women’s healthcare and reflects growing recognition of long-standing challenges across the NHS.


The strategy highlights several critical issues, including:

  • Delayed diagnosis

  • Inequitable access to care

  • Variability in patient experience

  • The need for earlier intervention and better pathways


At AGHealth, we welcome the renewed national focus on:

  • Faster and more accurate diagnosis

  • Improved patient pathways

  • Greater emphasis on patient voice and lived experience


However, meaningful progress will depend on successful implementation at a local level. Frontline teams must be equipped with the tools, training, and resources required to deliver sustainable improvements in care.


We look forward to continuing our partnerships with NHS organisations to help improve outcomes and experiences for women across the UK.




Upcoming Events & Educational Sessions


Conferences


AGHealth will be attending several important clinical events this spring and summer.


BGCS Annual Scientific Meeting

25–26 June 2026 | Bristol


NeoBEE – Neonatal Best Practice Education Event

Thursday 21 May 2026 | Solihull


Upcoming Webinar


DILAPAN-S Virtual Training Webinar

Friday 29 May 2026 | 12:00 PM




National Maternity Review: Current Priorities and Challenges


Progress continues against the ambitions outlined in the national maternity review, with ongoing focus on:

  • Personalised care pathways

  • Safer maternity services

  • Reducing health inequalities

  • Improving continuity of care


Despite this progress, NHS maternity services continue to face significant pressures, including workforce shortages and increasing clinical complexity.


As a result, many trusts are exploring solutions that can:

  • Support safe induction practices

  • Reduce avoidable admissions

  • Improve patient flow

  • Increase pathway efficiency


Mechanical cervical ripening methods and point-of-care diagnostics are playing an increasingly important role in helping services meet these challenges.


Learn more:


For further information or support, please contact the AGHealth team.



References

  1. Snowsill et al., 2026

Gynaecology medical devices UK

Thanks for joining!

G.004

30 Great Guildford Street

London, SE1 0HS

BSI certification logo
Maternity & Neonatal Medical Devices Supplier In The UK

Opening hours: Mon-Fri 9am-5:30pm

Registered as Advanced Global Health Ltd in England. Registration number 07181386

  • alt.text.label.LinkedIn
  • alt.text.label.Twitter
  • alt.text.label.YouTube
bottom of page